NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of…Read More

You might also be interested in reading SharpLink announces total ETH holdings increased to 797,704 as of August 24.